61 related articles for article (PubMed ID: 19877199)
1. A brief history of brain iron accumulation in Parkinson disease and related disorders.
Foley PB; Hare DJ; Double KL
J Neural Transm (Vienna); 2022 Jun; 129(5-6):505-520. PubMed ID: 35534717
[TBL] [Abstract][Full Text] [Related]
2. Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting.
Javidnia M; Frasier M; Shoulson I; Turkoz I; Budur K
Innov Clin Neurosci; 2020 Jan; 17(1-3):14-19. PubMed ID: 32547841
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?
Chahine LM; Stern MB
Mov Disord Clin Pract; 2017; 4(6):796-805. PubMed ID: 30363472
[TBL] [Abstract][Full Text] [Related]
4. Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini-Strambi L; Carli G; Casoni F; Galbiati A
Front Neurol; 2018; 9():551. PubMed ID: 30087647
[TBL] [Abstract][Full Text] [Related]
5. Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.
Hare DJ; Cardoso BR; Raven EP; Double KL; Finkelstein DI; Szymlek-Gay EA; Biggs BA
NPJ Parkinsons Dis; 2017; 3():1. PubMed ID: 28649601
[TBL] [Abstract][Full Text] [Related]
6. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
[TBL] [Abstract][Full Text] [Related]
7. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
[TBL] [Abstract][Full Text] [Related]
8. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
9. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.
Ayton S; Lei P
Biomed Res Int; 2014; 2014():581256. PubMed ID: 24527451
[TBL] [Abstract][Full Text] [Related]
10. Predicting parkinsonism: new opportunities from Gaucher disease.
Lopez G; Sidransky E
Mol Genet Metab; 2013 Jul; 109(3):235-6. PubMed ID: 23665160
[No Abstract] [Full Text] [Related]
11. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
12. Transcranial sonography in the early and differential diagnosis of Parkinson's disease.
Berg D
J Neural Transm Suppl; 2006; (70):249-54. PubMed ID: 17017537
[TBL] [Abstract][Full Text] [Related]
13. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
14. Transcranial ultrasound as a risk marker for Parkinson's disease.
Berg D
Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
[TBL] [Abstract][Full Text] [Related]
15. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
Berg D
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
